Full text is available at the source.
Abstract
The clinical use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is expanding across various health conditions.
- GLP-1 RAs are being used for managing type 2 diabetes.
- These medications may offer cardiovascular protection.
- There is potential for renal protection associated with GLP-1 RAs.
- GLP-1 RAs could be beneficial for noncirrhotic fatty liver disease.
- Weight management is another area where GLP-1 RAs are applied.
- The implications of GLP-1 RAs for oral health require further consideration.
Simplified